CMS Pub. 100-08, ch. 4, § 4.7.3.1.2

This section applies to UPICs. This section is applicable to DME MACs, RACs, SMRC,

and CERT MR contractors, as noted in Ch. 5, Section 5.8.

Early Delivery to an Inpatient Facility in Anticipation of Discharge

Exceptions to the preceding statements concerning the date(s) of service on the claim

occur when the items are provided in anticipation of discharge from an inpatient facility

that does not qualify as the beneficiary’s home. A supplier may deliver a DME,

prosthetics, or orthotics item (but not supplies) to a beneficiary in an inpatient facility that

does not qualify as the beneficiary’s home, for the purpose of fitting or training the

beneficiary in the proper use of the item. This delivery may be done up to two (2) days

prior to the beneficiary’s anticipated discharge to their home. The supplier must bill the

date of service on the claim as the date of discharge and the supplier must ensure that the

beneficiary takes the item home, or the supplier picks up the item at the facility and

delivers it to the beneficiary’s home on the date of discharge. The item must be medically

necessary on the date of discharge, i.e., there is a physician's order and corroborating

medical documentation to support a stated initial date of need that is no later than the date

of discharge for home use, and the item must be for subsequent use in the beneficiary’s

home.

(See IOM Pub. 100-04, Chapter 20, Section 110.3, for the policy and billing procedures

regarding the circumstances under which a supplier may deliver durable medical

equipment, prosthetics, and orthotics (but not supplies) to a beneficiary who is in an

inpatient facility that does not qualify as the beneficiary's home.)

Early Delivery to Home in Anticipation of Discharge

In some cases, it would be appropriate for a supplier to deliver a medically necessary

item of durable medical equipment (DME), a prosthetic, or an orthotic (but not supplies)

to a beneficiary’s home in anticipation of discharge to a Place of Service that qualifies as

home. A supplier may deliver an item of DME, a prosthetic or an orthotic to a

beneficiary’s home in anticipation of a discharge from a hospital or nursing facility. The

supplier may arrange for actual delivery of the item no sooner than two (2) days prior to

the beneficiary’s anticipated discharge to their home. The supplier shall bill the date of

service on the claim as the date of discharge and shall use the Place of Service (POS) as

12 (Patient’s Home).

Early Delivery of Immunosuppressive Drugs

Delivery of the immunosuppressive drugs may be made to the beneficiary’s home (i.e.,

his/her own dwelling, an apartment, a relative’s home, a home for the aged, or some

other type of institution— such as an assisted living facility, or an intermediate care

facility for individuals with intellectual disabilities (ICF/IID) but not a hospital or skilled

nursing facility). In certain cases, a beneficiary who has received a transplant does not

return home immediately after discharge. In order to ensure timely beneficiary access to

prescribed immunosuppressive medications at the time of discharge, suppliers may

deliver the initial prescriptions of a beneficiary’s immunosuppressive drugs to an

alternate address, such as the inpatient hospital that performed the transplant or

alternative location where the beneficiary is temporarily staying (e.g., temporary

housing), instead of delivering the drugs to the beneficiary’s home address.

To allow payment for the first immunosuppressive drug claim after the beneficiary is

discharged from an inpatient stay, the immunosuppressive drug may be mailed by a

supplier no earlier than two (2) days before a beneficiary is discharged from an inpatient

facility. The supplier must enter the date of discharge as the date of service on the claim.

Note that this is an optional, not mandatory, process. If the supplier chooses not to mail

the immunosuppressive drug(s) prior to the beneficiary’s date of discharge from the

hospital, they may wait for the beneficiary to be discharged before delivering the drugs,

and follow all applicable Medicare and DME MAC rules for immunosuppressive drug

billing (for example, the date of service will be the date of delivery). If the supplier ships

immunosuppressive drugs to an alternate address, all parties involved, including the

beneficiary and the transplant facility, must agree to the use of this approach. The

supplier will not receive additional payment for delivery to an alternate location.

Early and/or direct delivery to the transplant facility does not change the facility’s

responsibility to provide all immunosuppressive drugs required by the beneficiary for

the duration of the beneficiary’s inpatient stay.

(See IOM Pub. 100-04, Chapter 17, Section 80.3.3 for additional information.)

General Information

No billing may be made for any day prior to the date of discharge. A supplier may not

bill for drugs or other DMEPOS items used by the beneficiary prior to the beneficiary’s

discharge from a stay in an inpatient facility that does not qualify as the beneficiary’s

home. Billing the DME MAC for surgical dressings, urological supplies, or ostomy

supplies that are provided during a stay in an inpatient facility that does not qualify as

the beneficiary’s home is not allowed. These items are payable to the facility under Part

A of Medicare. This prohibition applies even if the item is worn home by the beneficiary

from the inpatient facility. Any attempt by the supplier and/or facility to substitute an

item that is payable to the supplier for an item that, under statute, should be provided by

the facility, may be considered to be fraudulent.

Separate payment will also not be available from either Medicare or the beneficiary if, for

any reason, redelivery is necessary. All other applicable Medicare and DME MAC billing

requirements continue to apply.